Auravax Therapeutics headquarters details
- Founded
- 2020
- Website
- auravax.com
About Auravax Therapeutics
Auravax Therapeutics: Biotechnology company offering COVID-19 vaccines. Founded in 2020, the company employs approximately 3 people worldwide.
What does Auravax Therapeutics do?
AuraVax Therapeutics, Inc. is a privately held biopharmaceutical company developing NanoSTING for the treatment and prevention of upper respiratory disease due to all major viral pathogens. This platform activates the STING pathway to trigger an effective innate immune response upon intranasal delivery. We are developing NanoSTING for global access to address the disease burden of current respiratory viruses and future emerging pathogens.
Frequently asked questions
When was Auravax Therapeutics founded?
Auravax Therapeutics was founded in 2020 and employs approximately 3 people.
How many employees does Auravax Therapeutics have?
Auravax Therapeutics has approximately 3 employees (GraphIQ estimate, 2026).